Pasouk knowledge-based company was stablished in 1994 to produce vaccines and biological products for veterinary medicine. In addition to meet the needs of the country and achieving self-sufficiency, innovation is at the forefront of goals. After the fulfillment of production and presentation of Newpasol 101, Newpasol 102 and Flupasol vaccines for the prevention and control of  two important diseases of poultry such as Newcastle and influenza, this company produced the new trivalent vaccine (Newpasol 103 ) for the first time in Iran and Gampasol for the prevention and control of  important diseases of poultry such as Newcastle, influenza  and Gumboro, also, it has produced highly pathogenic avian influenza strain (H5N8) and Newpasol 100 (NDV Strain GVII) vaccines. In addition, HI Antigens are produced for diagnostic tests of influenza and Newcastle disease.

All biological products of Pasouk Company are produced by using high quality raw materials such as SPF embryonated eggs and the best oil adjuvant (made by Pasouk) in accordance with the highest international standards and GMP principles which are distributed after accurate quality control and the approval of the Iran Veterinary Organization.

Watch Video
See additional description of Pasouk company here.